AIVITA’s lead therapeutic candidate is a patient-specific immunotherapy for the treatment of ovarian cancer. The treatment consists of autologous dendritic cells loaded with antigens derived from tumor-initiating cells. The therapy then is administered through a series of minimally invasive injections over the course of months.
AIVITA’s revolutionary stem cell-derived skin care technology helps address several key signs of skin aging, including the appearance of wrinkles, skin firmness, softness and radiance. AIVITA’s commercial line of skin care product, PROVOQUETM, is available through authorized physicians.